Fraser McLeod, Vice President of QA/QC for Waters Corporation, explains how Waters’s next-generation Alliance™ iS HPLC System will revolutionise productivity and efficiency for modern QC …
Highly potent drugs are becoming increasingly common in the drug development pipeline. The focus on oncology, rare diseases, and targeted therapies is growing even more acute. While …
Just proving that an intervention has benefits is not always enough for it to be adopted into clinical practice. Yet in the past, pharma Medical …
Tailoring medical treatment to the individual characteristics of patients based on genetic, environmental and lifestyle factors is quickly superseding more traditional clinical trial models. And …
● Pharmacy2U launches a new interactive timeline celebrating the most important medical discoveries and drugs that changed the face of medicine. ● The snapshot through …
A research team headed by Jean-Christophe Leroux from ETH Zurüch has created the first-ever 3-D printed mouth guard that could deliver drugs to the wearer …
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, has today published its findings on the discovery …
The CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. MJR PharmJet, partner ofleon-nanodrugs GmbH in drug development received one of …
Dr Jérôme Freissmuth at Robert Bosch GmbH discusses how present developments of new devices are increasingly focused on patients’ needs. They give top priority to simplified handling, reduced pain, continuous documentation and facilitated adherence to medication intervals.
Paul Strumph, Rick Turner and Associates at Quintiles introduce a new Commentary Series entitled Lessons Learned in Developing Cardiovascular and Metabolic Drugs, that will appear in each issue of this journal.
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
